Literature DB >> 28031565

Diabetes: Turning down galectin 3 to combat insulin resistance.

Katie Kingwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28031565     DOI： 10.1038/nrd.2016.276

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance.

Authors:  Pingping Li; Shuainan Liu; Min Lu; Gautum Bandyopadhyay; Dayoung Oh; Takeshi Imamura; Andrew M F Johnson; Dorothy Sears; Zhufang Shen; Bing Cui; Lijuan Kong; Shaocong Hou; Xiao Liang; Salvatore Iovino; Steven M Watkins; Wei Ying; Olivia Osborn; Joshua Wollam; Martin Brenner; Jerrold M Olefsky
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582
  1 in total
  2 in total

1.  Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus.

Authors:  Po-Wei Chen; Ling-Wei Hsu; Hsien-Yuan Chang; Ting-Chun Huang; Jia-Rong Yu; Hsin-Yu Liao; Cheng-Han Lee; Ping-Yen Liu
Journal:  Biomed Res Int       Date:  2019-04-08       Impact factor: 3.411

2.  Galectin-3 Is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes.

Authors:  A Lorenzo-Almorós; A Pello; Á Aceña; J Martínez-Milla; Ó González-Lorenzo; N Tarín; C Cristóbal; L M Blanco-Colio; J L Martín-Ventura; A Huelmos; C Gutiérrez-Landaluce; M López-Castillo; A Kallmeyer; E Cánovas; J Alonso; L López Bescós; J Egido; Ó Lorenzo; J Tuñón
Journal:  J Clin Med       Date:  2020-04-13       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.